Inspire Medical Systems Files 8-K on Officer/Director Changes
Ticker: INSP · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, compensation
Related Tickers: INSP
TL;DR
Inspire Medical Systems (INSP) filed an 8-K detailing leadership changes and compensation. Stay tuned for details.
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on August 26, 2025, reporting on events as of August 22, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and compensation structures, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially if unexpected, can signal internal shifts or strategic realignments that may carry risks.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — Registrant
- August 22, 2025 (date) — Earliest event date
- August 26, 2025 (date) — Filing date
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
Are there any new compensatory arrangements for officers detailed in this filing?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item covered, but the specifics of these arrangements are not provided in the excerpt.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed broadly to all investors, preventing selective disclosure.
What type of financial statements or exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the exact nature of these documents is not specified in the provided text.
When was Inspire Medical Systems, Inc. incorporated and what is its fiscal year end?
Inspire Medical Systems, Inc. was incorporated in Delaware and its fiscal year ends on December 31.
Filing Stats: 944 words · 4 min read · ~3 pages · Grade level 10.3 · Accepted 2025-08-26 17:02:24
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
Filing Documents
- insp-20250822.htm (8-K) — 31KB
- transitionandseparationa.htm (EX-10.1) — 39KB
- insp2025-08rbpressreleasee.htm (EX-99.1) — 13KB
- inspirelogo.jpg (GRAPHIC) — 14KB
- transitionandseparationa001.jpg (GRAPHIC) — 231KB
- transitionandseparationa002.jpg (GRAPHIC) — 317KB
- transitionandseparationa003.jpg (GRAPHIC) — 269KB
- transitionandseparationa004.jpg (GRAPHIC) — 320KB
- transitionandseparationa005.jpg (GRAPHIC) — 297KB
- transitionandseparationa006.jpg (GRAPHIC) — 301KB
- transitionandseparationa007.jpg (GRAPHIC) — 302KB
- transitionandseparationa008.jpg (GRAPHIC) — 123KB
- transitionandseparationa009.jpg (GRAPHIC) — 298KB
- transitionandseparationa010.jpg (GRAPHIC) — 308KB
- transitionandseparationa011.jpg (GRAPHIC) — 37KB
- 0001609550-25-000040.txt ( ) — 4100KB
- insp-20250822.xsd (EX-101.SCH) — 2KB
- insp-20250822_lab.xml (EX-101.LAB) — 22KB
- insp-20250822_pre.xml (EX-101.PRE) — 13KB
- insp-20250822_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 26, 2025, the Company issued a press release regarding the events described in Item 5.02. A copy of the press release is being furnished as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01 of Form 8-K and Exhibit 99.1 attached hereto is being furnished hereby and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated August 26 , 2025. 10.1 Transition and Separation Agreement by and between Inspire Medical Systems, Inc. and Richard J. Buchholz, dated August 26, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: August 26, 2025 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel 3